Mitchel Berger, MD
Affiliations: | 1997- | Neurosurgery | University of California, San Francisco, San Francisco, CA |
Google:
"Mitchel Berger"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Oberheim Bush NA, Yu Y, Villanueva-Meyer J, et al. (2020) Temozolomide-induced hypermutation is associated with high-grade transformation, distant recurrence, and reduced survival after transformation in initially low-grade IDH-mutant diffuse gliomas. Journal of Clinical Oncology. 38: 2506-2506 |
| Hervey-Jumper S, Molinaro A, Phillips J, et al. (2020) SURG-15. A NOVEL RISK MODEL TO DEFINE THE RELATIVE BENEFIT OF MAXIMAL EXTENT OF RESECTION WITHIN PROGNOSTIC GROUPS IN NEWLY DIAGNOSED DIFFUSE LOW-GRADE GLIOMA Neuro-Oncology. 22: ii206-ii206 |
| Lucas CG, Villanueva-Meyer JE, Whipple N, et al. (2019) Myxoid glioneuronal tumor, PDGFRA p.K385-mutant: clinical, radiologic, and histopathologic features. Brain Pathology (Zurich, Switzerland) |
| De Witte E, Piai V, Kurteff G, et al. (2019) A valid alternative for in-person language assessments in brain tumor patients: feasibility and validity measures of the new TeleLanguage test. Neuro-Oncology Practice. 6: 93-102 |
| Chandra A, Oh T, Wadhwa H, et al. (2019) RARE-30. PEDIATRIC GLIOBLASTOMA IN THE POST-TEMOZOLOMIDE ERA: OUTCOMES AND CHARACTERISTICS Neuro-Oncology. 21: vi227-vi228 |
| Young J, Zhang Y, Molinaro A, et al. (2019) RTHP-33. A SINGLE INSTITUTION RETROSPECTIVE ANALYSIS ON SURVIVAL BASED ON TREATMENT PARADIGMS FOR PATIENTS WITH ANAPLASTIC OLIGODENDROGLIOMA Neuro-Oncology. 21: vi216-vi217 |
| Chandra A, Kanungo I, Rick J, et al. (2019) QOLP-27. CLINICAL FACTORS AND MOLECULAR MARKERS ASSOCIATED WITH POSTOPERATIVE SEIZURES IN GLIOBLASTOMA Neuro-Oncology. 21: vi203-vi203 |
| Calixto-Hope L, Lee J, Sloan E, et al. (2019) PATH-38. ROSETTE-FORMING GLIONEURONAL TUMOR IS DEFINED BY FGFR1 ACTIVATING ALTERATIONS WITH FREQUENT ACCOMPANYING PI3K AND MAPK PATHWAY MUTATIONS Neuro-Oncology. 21: vi151-vi152 |
| Zhang M, Hilz S, Martin M, et al. (2019) IMMU-11. SPATIOTEMPORAL IMMUNOGENOMIC ANALYSIS OF THE T-CELL REPERTOIRE IN IDH-MUTANT LOWER GRADE GLIOMAS Neuro-Oncology. 21: vi121-vi121 |
| Hilz S, Hong C, Jalbert L, et al. (2019) GENE-47. A 3D ATLAS TO EVALUATE THE SPATIAL PATTERNING OF GENETIC ALTERATIONS AND TUMOR CELL STATES IN GLIOMA Neuro-Oncology. 21: vi107-vi108 |